AI Article Synopsis
- - Treatment of inflammatory bowel disease (IBD) in older adults poses challenges due to specific age-related characteristics that can complicate management.
- - New medical treatments for IBD emphasize not only symptom control but also prevention of disease progression, necessitating careful consideration of their safety for elderly patients.
- - Older patients often deal with comorbidities, polypharmacy, and altered drug metabolism, which elevate the risk of complications and adverse drug interactions during treatment.
Article Abstract
Although management of inflammatory bowel disease follows a similar approach for all adults, there are certain characteristics making its treatment more challenging in older patients. The advent of novel medical treatments has changed the paradigm of inflammatory bowel disease, with an increasing focus on preventing disease progression in addition to controlling symptoms. The safety of these therapies in the elderly needs to be considered. Management of inflammatory bowel disease in the elderly is confounded by comorbidities that can increase the risk of medication or surgical complications; polypharmacy and altered pharmacokinetics also increase the risk of drug-drug interactions and adverse events.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cger.2020.08.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!